CEB-01 in Locally Resectable Pancreatic Cancer

Clinical trial NCT06538857 · RECRUITING

Trial details

NCT number: NCT06538857
Sponsor: CEBIOTEX
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Carcinoma

Start date: 2024-08-20
Primary completion: 2028-09-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.